Venus Medtech Plans 500 Million Yuan Share, Convertible Bond Subscription
MT Newswires Live
2 hours ago
Venus Medtech (HKG:2500) entered into a subscription agreement with Hangzhou Yingzhiqin No. 3 Equity Investment Partnership for up to 500 million yuan of new shares and convertible bonds, according to a Thursday Hong Kong bourse filing.
The deal comprises 184.5 million new shares for about 171.9 million yuan and convertible bonds of up to HK$379.7 million.
The subscription price is HK$1.078 per share, while the initial conversion price is HK$1.1858.
The company said the fundraising will help address liquidity needs, meet near-term financial obligations, and support operations and product development.
The subscription remains subject to shareholder and other regulatory approvals.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.